CCO Independent Conference Coverage
|
American Society of Hematology 2009 Annual Meeting*
December 5-8, 2009 | New Orleans, Louisiana
*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.
Choose from 7 tracks of coverage (mouse over track for more info)
|
Expert Highlights
 |
Martin S. Tallman, MD, reviews highlights in acute myeloid leukemia and acute lymphoblastic leukemia, including treatment of younger adults, the role of FLT-3 inhibitors and other tyrosine kinase inhibitors, novel nucleoside analogues, and potential biologic markers for prognosis and prediction. (3 minutes) |
 |
Download Audio |
 |
Andre Goy, MD, MPH, summarizes the most compelling data in follicular lymphoma, diffuse large B-cell lymphoma, mantle cell lymphoma, and Hodgkin’s lymphoma presented at the 2009 Hematology meeting. (7 minutes) |
|
Download Audio |
 |
Kenneth Anderson, MD, shares developments in multiple myeloma, including maintenance therapy, novel drug combinations in relapsed refractory disease, and emerging data on new drugs, including second-generation proteasome inhibitors and a monoclonal antibody. (10 minutes) |
|
Download Audio |
 |
Neil P. Shah, MD, PhD, reviews highlights of studies in chronic myeloid leukemia, including the latest data in second-generation tyrosine kinase inhibitor therapy, treatment of imatinib-resistant disease, and the concept of discontinuation of therapy for patients who achieve complete molecular response. (9 minutes) |
|
Download Audio |
 |
Azra Raza, MD, highlights advances in dosing schedules and administration of hypomethylating agents and lenalidomide in select patient populations in MDS and summarizes the studies on new agents being investigated for this disease. (14 minutes) |
|
Download Audio |
Disclosures – Audio Expert Highlights
Kenneth Anderson, MD, has disclosed that he has received consulting fees from Celgene, Millennium, and Novartis.
Andre Goy, MD, MPH, has disclosed that he has received consulting fees from Celgene and Millennium; has received contracted research from Abbott Laboratories, Celgene, HGS, and Millennium; and has served on the speakers’ bureau for Genentech.
Azra Raza, MD, has disclosed that she has received consulting fees, fees for non-CME services, and contracted research from Celgene.
Neil P. Shah, MD, PhD, has disclosed that he has received consulting fees from Bristol-Myers Squibb and Novartis.
Martin S. Tallman, MD, has no significant financial relationships to disclose.
CCO Slidesets
Lymphomas
 |
|
In this slideset, James O. Armitage, MD, reviews Download slides on the most compelling data in lymphoma presented at the 2009 Hematology Annual Meeting.
Format: Microsoft PowerPoint (.ppt) |
File size: 1.72 MB
| Date posted: 1/7/2010
|
Advances in Myeloma
 |
|
In this slideset, Kenneth Anderson, MD, reviews the most clinically relevant studies in multiple myeloma presented at the 2009 Hematology meeting.
Format: Microsoft PowerPoint (.ppt) |
File size: 1.76 MB
| Date posted: 1/8/2010
|
Acute Leukemias and Myelodysplastic Syndromes
 |
|
Hagop Kantarjian MD, provides a slideset summary of the most notable studies in ALL, AML, and MDS presented at the 2009 Hematology Annual Meeting.
Format: Microsoft PowerPoint (.ppt) |
File size: 1.87 MB
| Date posted: 1/11/2010
|
|
Jointly sponsored by Annenberg Center for Health Sciences at Eisenhower and Clinical Care Options, LLC.
Contact Info
Educational grants provided by:
Educational grants support only the CME-certified components of this program.
Capsule Summary:
|